Provided by Tiger Trade Technology Pte. Ltd.

KALA BIO

0.4293
-0.0740-14.70%
Post-market: 0.43000.0007+0.16%19:59 EDT
Volume:29.43M
Turnover:17.72M
Market Cap:8.30M
PE:-0.01
High:0.5380
Open:0.5252
Low:0.4104
Close:0.5033
52wk High:95.50
52wk Low:0.4010
Shares:19.34M
Float Shares:18.59M
Volume Ratio:3.71
T/O Rate:158.35%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-72.4536
EPS(LYR):-165.5565
ROE:-345.32%
ROA:-65.43%
PB:0.92
PE(LYR):0.00

Loading ...

Kala Bio Signs LOI to Buy Nationwide Telehealth Platform for About $15 Million

Reuters
·
Sep 29

Kala Bio, Virotek Sign LOI with US DNA Testing Platform to Resell Genomic Tests

Reuters
·
Sep 24

KALA BIO and Virotek Sign Letter of Intent with U.S. DNA Testing Platform to Resell Virotek's Suite of Genetic Testing Products

THOMSON REUTERS
·
Sep 24

KALA BIO - Reselling Parties Expected to be Named in Coming Weeks

THOMSON REUTERS
·
Sep 24

Kala Bio Adds Healthcare Operator Yenvy Truong to Advisory Team

Reuters
·
Sep 17

Kala Bio Announces Annual Shareholder Meeting

Reuters
·
Sep 12

Kala Bio Enters Exclusive US Distribution Deal with Virotek for Ophthalmology Genetic Testing Program

Reuters
·
Sep 11

KALA BIO Updates Annual Meeting and Proposal Deadlines

TIPRANKS
·
Sep 10

Kala Bio Announces Next Annual Shareholder Meeting

Reuters
·
Sep 10

KALA BIO - Agreement Includes Right of First Refusal for Kala on Virotek Ophthalmology Products

THOMSON REUTERS
·
Sep 03

KALA BIO - Companies Agree to Profit-Sharing Structure Effective After Virotek Recovers Program Costs

THOMSON REUTERS
·
Sep 03

KALA BIO - to be Exclusive U.S. Distributor for Virotek Ophthalmology Genetic Testing for One Year

THOMSON REUTERS
·
Sep 03

KALA BIO and Virotek Finalize Definitive Agreement Establishing Exclusive U.S. Distribution Partnership for Ophthalmology Genetic Testing Program

THOMSON REUTERS
·
Sep 03

Kala Bio Signs LOI for Exclusive US Distribution of Virotek Ophthalmology Genetic Tests

Reuters
·
Sep 01

KALA BIO and Virotek Announce Letter of Intent to Establish an Exclusive U.S. Distribution Partnership for Ophthalmology Genetic Testing Program

THOMSON REUTERS
·
Sep 01

NASDAQ Trade Halt Volatility Trading Pause at 09:38 Am

Reuters
·
Aug 28

Kala Bio Faces NASDAQ Delisting After Stock Trades Below $1 for 30 Days

Reuters
·
Aug 28

Kala Bio Q2 EPS $(21.32) Up From $(85.64) YoY, Sales $0.00, Same YoY

Benzinga Earnings
·
Aug 20

Kala Bio Q2 Net Loss Narrows to $1.58 Million from Year-Ago $11.16 Million

Reuters
·
Aug 20

KALA BIO Announces Brief Delay in Quarterly Filing

TIPRANKS
·
Aug 15